| Name |
|---|
tofacitinib Gene SetFrom CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tofacitinib from the curated CTD Gene-Chemical Interactions dataset. |
Tofacitinib Gene Setinteracting proteins for the Tofacitinib drug from the curated DrugBank Drug Targets dataset. |
tofacitinib Gene SetFrom Guide to Pharmacology Chemical Ligands of Receptors receptors of the tofacitinib ligand (chemical) from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. |
Tofacitinib Gene SetFrom DeepCoverMOA Drug Mechanisms of Action proteins with high or low expression in Tofacitinib relative to other proteins from the DeepCoverMOA Drug Mechanisms of Action dataset. |
TOFACITINIB Gene Setinteracting proteins for the TOFACITINIB drug from theDGIdb Drug Targets 2026 dataset. |
Tofacitinib (citrate)_HS-578T Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SK-MEL-2 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SW 900 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_RPMI-7951 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_A-172 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_KATO III Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_BT-474 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_HT-29 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_LoVo Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SW480 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_COLO 205 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SW48 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_LS 180 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_RKO Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H460 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H2122 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_HOP62 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_A549 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H2030 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SHP-77 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SW 1271 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H1792 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_Hs 766T Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SNU-423 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_AsPC-1 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H596 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_A498 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_HCT15 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_Panc 03.27 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_C32 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_AN3 CA Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_HEC-1-A Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SNU-1 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_LOX-IMVI Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_CFPAC-1 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H1573 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_hTERT-HPNE Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_MIA PaCa-2 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_CHP-212 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H661 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H23 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_A-427 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_J82 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SW 1088 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_HepG2/C3A Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_PANC-1 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_H4 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_SW1417 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_C-33 A Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Tofacitinib (citrate)_NCI-H2347 Gene SetFrom Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. |
Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Response to tofacitinib treatment in psoriasis (herpes zoster) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Response to tofacitinib treatment in psoriasis (herpes zoster) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Response to tofacitinib treatment (herpes zoster)(time to event) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Response to tofacitinib treatment (herpes zoster)(time to event) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Response to tofacitinib treatment (herpes zoster) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Response to tofacitinib treatment (herpes zoster) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
TOFACITINIB CITRATE Gene Setinteracting proteins for the TOFACITINIB CITRATE drug from theDGIdb Drug Targets 2026 dataset. |